• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

无论是活菌还是死菌形式的普拉梭菌都能通过调节肠道菌群和短链脂肪酸生成来缓解屋尘螨诱导的变应性哮喘。

Both living and dead Faecalibacterium prausnitzii alleviate house dust mite-induced allergic asthma through the modulation of gut microbiota and short-chain fatty acid production.

机构信息

State Key Laboratory of Food Science and Technology, Jiangnan University, Wuxi, China.

School of Food Science and Technology, Jiangnan University, Wuxi, China.

出版信息

J Sci Food Agric. 2021 Oct;101(13):5563-5573. doi: 10.1002/jsfa.11207. Epub 2021 Apr 30.

DOI:10.1002/jsfa.11207
PMID:33709404
Abstract

BACKGROUND

Asthma is increasingly prevalent worldwide, and novel strategies to prevent or treat this disease are needed. Probiotic intervention has recently been reported to be effective for asthma prevention. Here, we explored the effects of Faecalibacterium prausnitzii on the development of allergic airway inflammation in a murine model of house dust mite (HDM)-induced allergic asthma.

RESULTS

Supplementation with living and dead F. prausnitzii blocked eosinophil, neutrophil, lymphocyte and macrophage influx and alleviated the pathological changes. Moreover, both living and dead F. prausnitzii administration decreased the levels of interleukin (IL)-4, IL-5, IL-13 and immunoglobulin G1, elevated regulatory T cell (Tregs) ratio, improved microbial dysbiosis and enhanced short-chain fatty acid (SCFA) production. Network correlation analysis revealed that the immune indicators were strongly associated with SCFA production. Based on the linear discriminant analysis effect size, Turicibacter was found to be the core genus related to HDM-induced asthma. Living F. prausnitzii treatment enriched Faecalibaculum, Dubosiella and Streptococcus, while dead F. prausnitzii treatment increased Muribaculaceae and Parabacteroides. Interestingly, both living and dead F. prausnitzii administration enriched Lachnoclostridium and normalized the pathways involving carbohydrate and lipid metabolism, which might be related to SCFA production.

CONCLUSION

Faecalibacterium prausnitzii exerts an anti-asthmatic effect partly by gut microbiota modulation and SCFA production, suggesting its potential as a probiotic agent for allergic asthma prevention. © 2021 Society of Chemical Industry.

摘要

背景

哮喘在全球范围内的发病率日益增高,因此需要新的策略来预防或治疗这种疾病。最近有报道称益生菌干预对预防哮喘有效。在这里,我们探索了粪真杆菌对屋尘螨(HDM)诱导的过敏性哮喘小鼠模型中过敏性气道炎症发展的影响。

结果

补充活菌和死菌粪真杆菌可阻止嗜酸性粒细胞、中性粒细胞、淋巴细胞和巨噬细胞浸润,并缓解病变。此外,活菌和死菌粪真杆菌给药均降低白细胞介素(IL)-4、IL-5、IL-13 和免疫球蛋白 G1 的水平,增加调节性 T 细胞(Tregs)的比例,改善微生物失调并增强短链脂肪酸(SCFA)的产生。网络相关分析表明,免疫指标与 SCFA 产生密切相关。基于线性判别分析效应大小,Turicibacter 被发现是与 HDM 诱导的哮喘相关的核心属。活菌粪真杆菌治疗可使 Faecalibaculum、Dubosiella 和 Streptococcus 丰度增加,而死菌粪真杆菌治疗可使 Muribaculaceae 和 Parabacteroides 丰度增加。有趣的是,活菌和死菌粪真杆菌给药均增加 Lachnoclostridium 并使涉及碳水化合物和脂质代谢的途径正常化,这可能与 SCFA 的产生有关。

结论

粪真杆菌通过调节肠道微生物群和产生 SCFA 发挥抗哮喘作用,表明其作为预防过敏性哮喘的益生菌制剂的潜力。 © 2021 英国化学学会。

相似文献

1
Both living and dead Faecalibacterium prausnitzii alleviate house dust mite-induced allergic asthma through the modulation of gut microbiota and short-chain fatty acid production.无论是活菌还是死菌形式的普拉梭菌都能通过调节肠道菌群和短链脂肪酸生成来缓解屋尘螨诱导的变应性哮喘。
J Sci Food Agric. 2021 Oct;101(13):5563-5573. doi: 10.1002/jsfa.11207. Epub 2021 Apr 30.
2
Reduced Akkermansia muciniphila and Faecalibacterium prausnitzii levels in the gut microbiota of children with allergic asthma.过敏性哮喘儿童肠道微生物群中嗜黏蛋白阿克曼氏菌和普拉梭菌水平降低。
Allergol Immunopathol (Madr). 2019 Jul-Aug;47(4):365-371. doi: 10.1016/j.aller.2018.12.009. Epub 2019 Feb 11.
3
Specific Strains of Ameliorate Nonalcoholic Fatty Liver Disease in Mice in Association with Gut Microbiota Regulation.特定菌株通过调节肠道微生物群改善小鼠非酒精性脂肪肝病。
Nutrients. 2022 Jul 19;14(14):2945. doi: 10.3390/nu14142945.
4
Faecalibacterium prausnitzii alleviates inflammatory arthritis and regulates IL-17 production, short chain fatty acids, and the intestinal microbial flora in experimental mouse model for rheumatoid arthritis.普拉梭菌(Faecalibacterium prausnitzii)可缓解炎症性关节炎,并调节实验性类风湿关节炎小鼠模型中的白细胞介素-17(IL-17)产生、短链脂肪酸和肠道微生物菌群。
Arthritis Res Ther. 2023 Jul 26;25(1):130. doi: 10.1186/s13075-023-03118-3.
5
Anti-Inflammatory Activities of Pentaherbs formula and Its Influence on Gut Microbiota in Allergic Asthma.五草方的抗炎活性及其对过敏性哮喘肠道微生物群的影响。
Molecules. 2018 Oct 26;23(11):2776. doi: 10.3390/molecules23112776.
6
Alter between gut bacteria and blood metabolites and the anti-tumor effects of Faecalibacterium prausnitzii in breast cancer.肠道细菌和血液代谢物的变化与普拉梭菌在乳腺癌中的抗肿瘤作用。
BMC Microbiol. 2020 Apr 9;20(1):82. doi: 10.1186/s12866-020-01739-1.
7
Lactobacillus reuteri attenuated allergic inflammation induced by HDM in the mouse and modulated gut microbes.罗伊氏乳杆菌减轻了 HDM 诱导的小鼠变应性炎症,并调节了肠道微生物。
PLoS One. 2020 Apr 21;15(4):e0231865. doi: 10.1371/journal.pone.0231865. eCollection 2020.
8
The development of allergic inflammation in a murine house dust mite asthma model is suppressed by synbiotic mixtures of non-digestible oligosaccharides and Bifidobacterium breve M-16V.在小鼠屋尘螨哮喘模型中,不可消化的低聚糖与短双歧杆菌M-16V的合生元混合物可抑制变应性炎症的发展。
Eur J Nutr. 2016 Apr;55(3):1141-51. doi: 10.1007/s00394-015-0928-8. Epub 2015 May 24.
9
Supplementation Prevents Intestinal Barrier Injury and Gut Microflora Dysbiosis Induced by Sleep Deprivation.补充剂可预防睡眠剥夺引起的肠道屏障损伤和肠道微生物群失调。
Nutrients. 2024 Apr 9;16(8):1100. doi: 10.3390/nu16081100.
10
OX40 blockade inhibits house dust mite driven allergic lung inflammation in mice and in vitro allergic responses in humans.OX40 阻断抑制屋尘螨诱导的小鼠过敏性肺部炎症和体外人类过敏性反应。
Eur J Immunol. 2015 Apr;45(4):1116-28. doi: 10.1002/eji.201445163. Epub 2015 Jan 21.

引用本文的文献

1
Gut-lung axis in allergic asthma: microbiota-driven immune dysregulation and therapeutic strategies.过敏性哮喘中的肠-肺轴:微生物群驱动的免疫失调及治疗策略
Front Pharmacol. 2025 Jul 31;16:1617546. doi: 10.3389/fphar.2025.1617546. eCollection 2025.
2
Lung Acetate Levels Decline in Correlation With Increased Type 2 Allergic Markers in a House Dust Mite Allergic Mouse Model.在屋尘螨过敏性小鼠模型中,肺乙酸盐水平下降与2型过敏标志物增加相关。
Clin Transl Allergy. 2025 Aug;15(8):e70082. doi: 10.1002/clt2.70082.
3
The potential effect of gut microbiota on the secretion of selected cytokines by human cells in vitro.
肠道微生物群对人细胞体外分泌特定细胞因子的潜在影响。
Sci Rep. 2025 May 19;15(1):17367. doi: 10.1038/s41598-025-01581-3.
4
Multi-omics analyses reveal differences in intestinal flora composition and serum metabolites in Cherry Valley broiler ducks of different body weights.多组学分析揭示不同体重樱桃谷肉鸭肠道菌群组成和血清代谢物的差异。
Poult Sci. 2025 May 7;104(8):105275. doi: 10.1016/j.psj.2025.105275.
5
Gut microbiota and plasma metabolites in pregnant mothers and infant atopic dermatitis: A multi-omics study.孕妇和婴儿特应性皮炎中的肠道微生物群和血浆代谢物:一项多组学研究。
World Allergy Organ J. 2025 Jan 2;18(1):101017. doi: 10.1016/j.waojou.2024.101017. eCollection 2025 Jan.
6
Impact of calsporin® (Bacillus subtilis C-3102) supplementation on growth performance and intestinal function in geese.添加Calsporin®(枯草芽孢杆菌C-3102)对鹅生长性能和肠道功能的影响。
Poult Sci. 2025 Feb;104(2):104711. doi: 10.1016/j.psj.2024.104711. Epub 2024 Dec 19.
7
The gut microbiota modulates airway inflammation in allergic asthma through the gut-lung axis related immune modulation: A review.肠道微生物群通过肠-肺轴相关免疫调节作用调节过敏性哮喘中的气道炎症:综述
Biomol Biomed. 2025 Mar 7;25(4):727-738. doi: 10.17305/bb.2024.11280.
8
Traditional Chinese medicine to improve immune imbalance of asthma: focus on the adjustment of gut microbiota.中医改善哮喘免疫失衡:聚焦肠道微生物群的调节
Front Microbiol. 2024 Oct 1;15:1409128. doi: 10.3389/fmicb.2024.1409128. eCollection 2024.
9
Exploration of the Family in the Gut Microbiota: Diversity, Metabolism, and Function.肠道微生物组中的家庭探索:多样性、代谢和功能。
Nutrients. 2024 Aug 12;16(16):2660. doi: 10.3390/nu16162660.
10
Association Between Gut and Nasal Microbiota and Allergic Rhinitis: A Systematic Review.肠道和鼻腔微生物群与变应性鼻炎之间的关联:一项系统评价。
J Asthma Allergy. 2024 Jul 9;17:633-651. doi: 10.2147/JAA.S472632. eCollection 2024.